0001576280-21-000040.txt : 20210414 0001576280-21-000040.hdr.sgml : 20210414 20210414180614 ACCESSION NUMBER: 0001576280-21-000040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210412 FILED AS OF DATE: 20210414 DATE AS OF CHANGE: 20210414 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MERESMAN STANLEY J CENTRAL INDEX KEY: 0001283102 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 21826782 MAIL ADDRESS: STREET 1: 2071 HUNTINGTON LANE CITY: LOS ALTOS STATE: CA ZIP: 94024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 PENOBSCOT DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 505 PENOBSCOT DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 wf-form4_161843795575355.xml FORM 4 X0306 4 2021-04-12 0 0001576280 Guardant Health, Inc. GH 0001283102 MERESMAN STANLEY J 505 PENOBSCOT DRIVE REDWOOD CITY CA 94063 1 0 0 0 COMMON STOCK 2021-04-12 4 M 0 4934 5.94 A 8993 D COMMON STOCK 2021-04-12 4 S 0 1606 151.9062 D 7387 D COMMON STOCK 2021-04-12 4 S 0 594 152.9892 D 6793 D COMMON STOCK 2021-04-12 4 S 0 1584 154.4676 D 5209 D COMMON STOCK 2021-04-12 4 S 0 940 155.4639 D 4269 D COMMON STOCK 2021-04-12 4 S 0 210 156.5867 D 4059 D STOCK OPTION (RIGHT TO BUY) 5.94 2021-04-12 4 M 0 4934 0 D 2028-05-09 COMMON STOCK 4934.0 64143 D These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.71 to $152.305, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.76 to $153.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $154.055 to $155.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $155.11 to $156.015, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $156.12 to $156.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. /s/ John Saia, as attorney-in-fact for Stanley J Meresman 2021-04-14